THORLNC and breast carcinoma: Furthermore, as epigenome editing tools have been successfully applied in vivo, demethylation of THOR and its biological effects should be further studied as it might constitute a promising therapeutic target for breast cancer, as well as for other telomerase-dependent cancers.